Strattera heart risk

You are currently browsing articles tagged Strattera heart risk.

The Therapeutic Goods Administration (TGA) has issued a new safety advisory for Strattera, the non-stimulant drug once touted as a safe alternative to ADHD stimulants. Strattera already carries warnings for serious adverse events including suicidal ideation and potential fatal liver damage. The TGA has now added a warning about ‘clinically significant increases in heart rate and blood pressure’. (The new warning is available at

Read the rest of this entry »

Tags: , ,